Synthetic protein scaffolds provide modular control over metabolic flux

Engineered metabolic pathways are usually devoid of the regulatory mechanisms characteristic of natural metabolism. Using pathways not normally found in E. coli , Dueber et al . show that synthetic scaffolds built using protein-protein interaction domains can boost yields of mevalonate and glucaric...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2009-08, Vol.27 (8), p.753-759
Hauptverfasser: Dueber, John E, Wu, Gabriel C, Malmirchegini, G Reza, Moon, Tae Seok, Petzold, Christopher J, Ullal, Adeeti V, Prather, Kristala L J, Keasling, Jay D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Engineered metabolic pathways are usually devoid of the regulatory mechanisms characteristic of natural metabolism. Using pathways not normally found in E. coli , Dueber et al . show that synthetic scaffolds built using protein-protein interaction domains can boost yields of mevalonate and glucaric acid. Engineered metabolic pathways constructed from enzymes heterologous to the production host often suffer from flux imbalances, as they typically lack the regulatory mechanisms characteristic of natural metabolism. In an attempt to increase the effective concentration of each component of a pathway of interest, we built synthetic protein scaffolds that spatially recruit metabolic enzymes in a designable manner. Scaffolds bearing interaction domains from metazoan signaling proteins specifically accrue pathway enzymes tagged with their cognate peptide ligands. The natural modularity of these domains enabled us to optimize the stoichiometry of three mevalonate biosynthetic enzymes recruited to a synthetic complex and thereby achieve 77-fold improvement in product titer with low enzyme expression and reduced metabolic load. One of the same scaffolds was used to triple the yield of glucaric acid, despite high titers (0.5 g/l) without the synthetic complex. These strategies should prove generalizeable to other metabolic pathways and programmable for fine-tuning pathway flux.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.1557